Brief: VBI Vaccines Says Its Hepatitis B Vaccine Recommended By CDC Advisory Committee
23/02/2022 21:55
Feb 23 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES ANNOUNCES PREHEVBRIO™ [HEPATITIS B VACCINE
(RECOMBINANT)] RECOMMENDED BY CDC ADVISORY COMMITTEE ON
IMMUNIZATION PRACTICES FOR THE PREVENTION OF HEPATITIS B IN
ADULTS
* VBI VACCINES INC - VACCINE AVAILABILITY IS EXPECTED TO
BEGIN
LATER IN Q1 2022
Source text for Eikon: ID:nBw3GlGbya
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55